BPA Call HT942523A0001-HT009024FG0810028
Award Date 8/13/24
Potential Completion Date 9/30/24
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Round Rock, TX 78665, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price contract was awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a foreign-owned, for-profit manufacturer located in Round Rock, Texas. The contract, valued at $10,317.66, is for the provision of drug standards needed for screening and testing of service member specimens. The contract is a blanket purchase agreement (BPA) call and does not have a set-aside designation. Cerilliant is a longtime provider of certified reference standards and materials to...
- This federal contract award to Cerilliant Corporation, a foreign-owned manufacturer based in Round Rock, Texas, is for the supply of drug standards used for screening and confirmation testing of urine, blood, and tissue samples from service members suspected of drug use. The $10,010.88 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), a defense agency. Cerilliant, which has over 30 years of experience as a government contractor, will...
- This is a federal contract award to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference materials based in Round Rock, Texas. The contract, awarded by the Defense Health Agency (DHA), is for the provision of medical supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type and a ceiling value of $32,348.38. The contract is set to expire on September 30, 2023. Cerilliant Corporation has a history of...
- This federal contract award is a Blanket Purchase Agreement (BPA) call issued by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials and laboratory supplies. The contract, valued at $8,279.36, is for the provision of drug reference standards to support the DHA's drug screening and testing programs for service members. Cerilliant Corporation is a foreign-owned, for-profit manufacturer based in Texas, with over 30 years of experience as a...
- This is a BPA (Blanket Purchase Agreement) call awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials. The contract, valued at $11,104.95, is for the supply of FTDTL (Forensic Toxicology Drug Testing Laboratory) Cerilliant supplies for the Fort Meade location. This BPA call is part of a larger $250,000 DHA BPA that Cerilliant holds to provide drug reference standards through September 2028. Cerilliant, a foreign-owned, for-profit...
- This firm fixed-price contract award to Cerilliant Corporation, a foreign-owned for-profit manufacturer, is for the provision of drug standards that will be used for screening and testing of service members' specimens. The contract, valued at $12,538.24, was awarded by the Defense Health Agency on March 26, 2024, with a completion date of September 30, 2024. This appears to be a call under a larger Blanket Purchase Agreement (BPA) vehicle, as the contract type is listed as "BPA...
- Cerilliant Corporation was awarded a $19,723.40 firm fixed price blanket purchase agreement call from the Defense Health Agency to provide drug supplies. As a global leader in certified reference standards for over 30 years, Cerilliant will deliver chemical reference materials from its Round Rock, Texas headquarters to support agency testing and healthcare programs at the place of performance in Fort Meade, Maryland. Cerilliant currently holds several indefinite delivery/indefinite quantity...
- Cerilliant Corporation, a foreign-owned manufacturer, was awarded a firm fixed price BPA call contract by the Defense Health Agency to provide products for screening and analysis of suspected drug use. The $12,175.61 contract has a completion date of September 30, 2024 and does not utilize any set-aside designations. Cerilliant is a long-standing federal contractor, delivering certified reference standards, reagents, and laboratory materials to support research, testing, and healthcare...
- This federal contract award to Cerilliant Corporation is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), valued at $15,522.70. The contract is for the provision of drug reference standards and calibration materials to support drug testing and screening of service member specimens, including post-mortem urine, blood, and tissue samples. The contract has a completion date of August 15, 2024 and is a firm fixed price arrangement. Cerilliant Corporation is a global...
- Cerilliant Corporation was awarded a $13,064.06 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide laboratory supplies. The contract has no set-aside designation and runs from the May 19, 2023 award date through the May 19, 2023 completion date. Cerilliant will deliver the requested chemical and biological reference standards and calibrators to support the agency's laboratory programs from their place of performance in Fort Meade, Maryland. No...